TrialOncology2016

The New Combination Docetaxel, Prednisone and Curcumin in Patients with Castration-Resistant Prostate Cancer: A Pilot Phase II Study.

Hakim Mahammedi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.